Transcatheter Embolization and Occlusion Devices – Market Insights – Latin America

Although COVID-19 has negatively impacted the Latin American transcatheter embolization and occlusion device market, the impact of COVID-19 has been limited. The market will expand at a modest rate over the forecast period due largely to growing adoption of minimally invasive treatment option such as embolization and adoption of advanced TEO devices supported by favorable clinical trial results.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for TEO devices in Latin America from 2019 through 2031.

The TEO device market was impacted by the COVID-19 pandemic in the short term but has begun to see a recovery toward prepandemic levels.

Which procedures were most impacted by the pandemic?

What will the recoveries look like for different procedure categories over the forecast period?

The neurovascular flow-diverting device market is seeing modest growth.

How will the adoption of neurovascular flow-diverting devices impact the neurovascular embolization coil and coiling-assist device markets?

Which strategies are competitors adopting to gain a competitive edge over other competitors in the neurovascular flow-diverting device market?

How has the competitive landscape changed with the emergence of new competitors and products?

Cost constrained nature of countries in the region will limit Latin American TEO device market.

How fast will ASPs erode and which countries will experience the greatest erosion?

How can companies mitigate this downward pricing pressure?

Table of contents